We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Overcoming Challenges in Biopharma: Transformational Innovation is Key

Article   Jan 07, 2019 | by Lisa Sapp (Biopharma Market Manager, Agilent Technologies) and Ning Tang (Biopharma Segment Marketing Manager, Agilent Technologies)

 
Overcoming Challenges in Biopharma: Transformational Innovation is Key
 
 
Advertisement
 

RELATED ARTICLES

The Coronavirus Outbreak

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

READ MORE

Talking Viral Mutations, Genome Sequencing and Antigenic Drift With Dr Timothy Triche

Article

Technology Networks interviewed Dr Timothy Triche to gain his perspectives on how analysis of unique strains can help to define the scope and severity of COVID-19, why this is a complex process and the possible negative implications of antigenic drift.

READ MORE

Antimicrobial Resistance

Article

Antimicrobial resistance (AMR) is the ability of microorganisms to resist the killing capacity of antimicrobial drugs, a worryingly increasing problem. This article explores the science behind AMR, factors promoting it's spread and techniques to detect it. Looking to the future, ways to combat AMR and alternatives to antimicrobials are discussed.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cancer Research Cell Science Diagnostics Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE